Evidence map›Paper›PMID 40817158›Full record

ReviewDiscover oncology2025

Radiomics in pediatric brain tumors: from images to insights.

Pranjal Rai, Sabha Ahmed, Abhishek Mahajan

Abstract readReview
In one paragraph

Review in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pranjal RaiMayo Clinic, Rochester, MN, USA.
Sabha AhmedNational Institute of Mental Health and Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.
Abhishek MahajanDepartment of Imaging, The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool, L7 8YA, UK. abhishek.mahajan@nhs.net.ORCID http://orcid.org/0000-0001-6606-6537

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiomics has emerged as a promising non-invasive imaging approach in pediatric neuro-oncology, offering the ability to extract high-dimensional quantitative features from routine MRI to support diagnosis, risk stratification, molecular characterization, and outcome prediction. Pediatric brain tumors, which differ significantly from adult tumors in biology and imaging appearance, present unique diagnostic and prognostic challenges. By integrating radiomics with machine learning algorithms, studies have demonstrated strong performance in classifying tumor types such as medulloblastoma, ependymoma, and gliomas, and predicting molecular subgroups and mutations such as H3K27M and BRAF. Recent studies combining radiomics with machine learning algorithms - including support vector machines, random forests, and deep learning CNNs - have demonstrated promising performance, with AUCs ranging from 0.75 to 0.98 for tumor classification and 0.77 to 0.88 for molecular subgroup prediction, across cohorts from 50 to over 450 patients, with internal cross-validation and external validation in some cases. In resource-limited settings or regions with limited radiologist manpower, radiomics-based tools could help augment diagnostic accuracy and consistency, serving as decision support to prioritize patients for further evaluation or biopsy. Emerging applications such as radio-immunomics and radio-pathomics may further enhance understanding of tumor biology but remain investigational. Despite its potential, clinical translation faces notable barriers, including limited pediatric-specific datasets, variable imaging protocols, and the lack of standardized, reproducible workflows. Multi-institutional collaboration, harmonized pipelines, and prospective validation are essential next steps. Radiomics should be viewed as a supplementary tool that complements existing clinical and pathological frameworks, supporting more informed and equitable care in pediatric brain tumor management.

Indexed as

Machine learningMedulloblastomaMolecular imagingMRIPediatric brain tumorsRadiomics

Identifiers

PMID40817158
PMCPMC12356798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.